Reported by CNBC’s Melissa Lee, the hour-long program looks at how diabetes drugs have reinvented the weight loss business and diet culture in America
Englewood Cliffs, NJ – February 22, 2024 – In CNBC’s newest one-hour documentary, “Big Shot: The Ozempic Revolution,” CNBC will give audiences an in-depth look at how diabetes drug Ozempic has reinvented weight loss culture and the way obesity is treated in America. CNBC’s Melissa Lee travels to Denmark to get a rare look inside the headquarters, labs and a future manufacturing facility of Ozempic maker, Novo Nordisk. The documentary will debut globally on CNBC on Thursday, February 29 at 10PM ET/PT.
The Danish pharmaceutical company, Novo Nordisk, long known for diabetes treatments, has become a global powerhouse. Its success with Ozempic is fueling fierce competition among pharmaceutical companies to create newer and even more effective versions of these drugs focusing on weight loss. With immense interest in medications like Wegovy, and Eli Lilly’s Zepbound. Analysts project the global anti-obesity drug market may balloon from close to $6 billion in 2023 to $100 billion by 2030.
In “Big Shot: The Ozempic Revolution,” CNBC takes a comprehensive, deep dive into this unfolding story, exploring the consequences of the brand name drug’s eye-popping price tags, the struggle to get the medications to those who need them, and the controversial role of compounding pharmacies and telehealth services competing to meet the demand and capture a share of the market. Lee also talks with doctors and patients to reveal the real-time pros and cons of these cutting-edge medications that some say may have a greater impact on our culture than A.I.
For more information about the documentary, visit cnbc.com/big-shot-the-ozempic-revolution.
About CNBC
CNBC is the recognized world leader in business news, providing real-time financial market coverage and business content consumed by more than half a billion people per month across all platforms. The network’s 15 live hours a day of news programming in North America (weekdays from 5:00 a.m. – 8:00 p.m. ET) is produced at CNBC’s global headquarters in Englewood Cliffs, N.J., and includes reports from CNBC News bureaus worldwide. CNBC at night features a mix of reality programming, CNBC’s highly successful series produced exclusively for CNBC and a number of distinctive in-house documentaries.
CNBC also offers content through its vast portfolio of digital products such as: CNBC.com, which provides financial market news and information to CNBC’s investor audience; CNBC Make It, a digital destination focused on making you smarter about how you earn, save and spend your money; CNBC PRO, a premium service that provides in-depth access to Wall Street; a suite of CNBC mobile apps for iOS and Android devices; Amazon Alexa, Google Assistant and Apple Siri voice interfaces; and streaming services including Apple TV, Roku, Amazon Fire TV, Android TV and Samsung Smart TVs. To learn more, visit cnbc.com/digital-products.
Members of the media can receive more information about CNBC and its programming on the NBCUniversal Media Village Web site at nbcumv.com/programming/cnbc. For more information about NBCUniversal, please visit nbcuniversal.com.
